Pediatric Rheumatology

Influenza Vaccination Rate

Influenza (flu) is a highly contagious respiratory illness. During the 2017-2018 flu season there were an estimated 79,000 deaths. The best way to prevent flu is by getting a flu vaccine each year. At Cleveland Clinic Children’s, Center for Pediatric Rheumatology, one of our top priorities is to educate our families and vaccinate our immunocompromised patient population. Children with pediatric rheumatic disease, often require immunmodulator medication, such as tumor necrosis inhibitors (TNF- inhibitors), to control their disease making them more susceptible to illness. The table below represents our effort to ensure our patients taking TNF- inhibitors are offered and delivered the safest and highest quality of care, while adhering to Cleveland Clinic’s mission.

Influenza Immunization in Pediatric Rheumatology Patients on TNF Inhibitors (N = 93)


In 2018, the providers reviewed and counseled the importance of annual influenza vaccine with 87% of patients on TNF inhibitors. The overall compliance rate in these at risk patients was 94%. The department’s immunization rate is above the National Immunization Survey Flu- vaccination rate (2017-2018) of 57.9% for patients age 6 months to 17 years.